NCT02133599View on ClinicalTrials.gov

Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 24, 2014

Primary Completion Date

February 26, 2019

Study Completion Date

February 27, 2019

Conditions
ALL
Interventions
DRUG

IOHEXOL

Patients receive 5 mL of Iohexol prior to cycle 1 and 4 of HDMTX

Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hosptial of Chicago, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT02133599 - Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL | Biotech Hunter | Biotech Hunter